Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-07

Clinical Trial Update: To Document the Burden of Illness on the Quality of Life and the Impact on Healthcare Utilization in (Beta) β-thalassemia Subjects Who Are Transfusion Dependent (TD) and Non-transfusion Dependent (NTD) Receiving Standard of Care

View source ↗

Summary

This completed clinical trial documents the burden of illness on quality of life and healthcare utilization among transfusion-dependent and non-transfusion-depe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Celgene | Conditions: Beta-Thalassemia | Status: COMPLETED